Similar Articles |
|
The Motley Fool June 7, 2006 Brian Gorman |
Martek's Formula for Success Dependence on one customer could spell trouble for this nutritional supplement maker. Investors, take note. |
The Motley Fool June 8, 2005 T.G. Wolf |
Popping Martek's Bubble An abundance of algae, used to make the DHA and ARA in baby formula, weighs on this biosciences company. Investors may want to exercise caution here. |
The Motley Fool September 7, 2006 Brian Lawler |
Where's the Love for Martek? What could explain a company reporting a 78% increase in quarterly revenues, yet also being the biggest percentage loser of the day on the Nasdaq? Answer: Guidance for the fourth quarter that is well below what analysts were expecting. |
The Motley Fool September 5, 2008 Brian Orelli |
The Right Formula in Any Economy Babies have to eat, so nutritional supplement maker Martek Biosciences is still thriving. |
Nutra Solutions September 1, 2005 |
Delivering DHA Martek DHA is a vegetarian source of DHA with a ready-made market of moms who know the importance of DHA for brain and eye development. |
BusinessWeek August 30, 2004 Gene G. Marcial |
Martek: Bringing Up Baby Shares of the baby food maker's stock, at 70 in May, fell to 45 in July when worries rose that it might fail to meet demand. The stock is now at 51, as supplies keep rising. |
The Motley Fool December 12, 2008 Brian Orelli |
Martek Meanders Through the Year Even though growth seems to be slowing down, Infant-supplement maker Martek Biosciences is in a pretty good position. |
Prepared Foods February 4, 2006 Marcia A. Wade |
Loose Lipids While every oil has its "strengths and weaknesses," what matters most is how a particular type of oil affects the Nutrition Facts panel. |
The Motley Fool December 21, 2010 Brian D. Pacampara |
Martek Biosciences Shares Skyrocketed: What You Need to Know Martek Biosciences saw its shares soar a staggering 35% in early Tuesday trading after Dutch vitamin giant Royal DSM NV said it will bid $1.09 billion for the company. |
The Motley Fool September 13, 2006 Tim Beyers |
Who's Buying Now? Sometimes insiders are buying for all the right reasons. Who's buying now? Human Genome Sciences... Martek Biosciences... MasterCard... Pinnacle Entertainment... U-Store-It Trust... |
Food Processing June 2012 Mark Anthony |
Is Algae DHA As Healthy as Fish Oil DHA? A review of research earlier this year found mostly good news in this vegetarian source. |
Food Processing August 2009 Diane Toops |
Health 101: Understanding Omega-3 Fatty Acids Consumers are embracing omega-3, omega-6, and omega-9 for longer, healthier lives. |
The Motley Fool January 4, 2011 Seth Jayson |
Should You Get Out of Martek Biosciences Before Next Quarter? For the last fully reported fiscal quarter, Martek Biosciences' year-over-year revenue grew 36%, and its AR grew 57%. That's a yellow flag. |
Food Processing September 2009 Diane Toops |
(O)mega Opportunities arise with Omega Fatty Acids Higher-income, health-conscious shoppers are seeking foods with omega fatty acids. |
Food Processing August 2010 Fusaro & Toops |
Food Processors Welcome A Gush of Omega Oils Market reports and news at the IFT expo show a flood of interest in omega-3 oils. |